Osteoadsorptive Fluorogenic Probe for Cathepsin K Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current fluorescent probes for imaging cathepsin K activity in vivo have a short half-life, limiting the duration for which bone resorption can be monitored, as they are cleared from the body within a few days, necessitating imaging within 24 hours of injection.
Innovation Solution
Development of osteoabsorptive fluorogenic probes with a bisphosphonate targeting moiety linked to a cleavable fluorophore-quencher pair, which are designed to remain active for longer periods by targeting bone surfaces, allowing for extended monitoring of cathepsin K activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional fluorescent probes are used for imaging cathepsin K activity, then the probes can be injected and imaged soon after administration, but the probes are cleared from the body within a few days, limiting the monitoring duration to within 24 hours
Solution Approach 1:
The probe incorporates a bisphosphonate moiety that provides selective affinity for bone surfaces, causing the probe to accumulate locally at the target site rather than being uniformly distributed and cleared systemically. This localized accumulation at bone surfaces extends the effective monitoring duration while maintaining reliable fluorescent signal strength at the target site.
Solution Approach 2:
The probe is designed as a composite molecule combining a bisphosphonate targeting moiety with a fluorogenic substrate specific for cathepsin K. This composite structure integrates the bone-targeting capability of bisphosphonates with the enzymatic specificity of the fluorogenic substrate, enabling both prolonged retention at bone surfaces and specific detection of cathepsin K activity.
2Duration of action of moving object
If the probe is designed to remain active for longer periods by targeting bone surfaces, then extended monitoring is enabled, but the probe structure becomes more complex with additional targeting moieties
Solution Approach 1:
The probe merges the bone-targeting function of bisphosphonates with the cathepsin K-specific fluorogenic substrate into a single integrated molecule. This combination achieves prolonged monitoring duration through bone surface accumulation while maintaining relatively simple probe structure by using a well-established bisphosphonate scaffold rather than adding separate targeting and detection components.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The probes enable prolonged monitoring of cathepsin K activity at bone surfaces, providing a detectable signal for up to several days with a single dose, facilitating the assessment of bone resorption processes and related pathologies.
Implementation Method 1
osteoadsorptive fluorogenic substrates of cathepsin K
Implementation Method 2
two self-quenching fluorophores or a fluorophore and a quencher are connected by a linker. In the intact state these molecules have weak fluorescence as the fluorophore is quenched by contact with another fluorophore or via Forster resonance energy transfer
Implementation Method 3
Upon cleavage of the linker, the pair of chromophores is separated and the quenching process can no longer occur efficiently. The fluorophore then can emit stronger fluorescence.
Data Source
AI summary
In certain embodiments osteoadsorptive fluorogenic substrates of cathepsin K (or other proteases) are provided. Utilizing a bisphosphonate targeting moiety, the fluorogenic substrates provide effective bone-targeted protease sensor(s). In certain embodiments the “probes” comprise cleavable fluorophore-quencher pair linked by a cathepsin K (or other protease) peptide substrate and tethered to a bisphosphonate. Unlike existing probes that are cleared within a few days in vivo, the probes described herein (e.g., OFS-1) allow for monitoring resorption over the course of longer time periods with a single dose.